SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 162 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $48,000 | -27.3% | 1,756 | +62.0% | 0.00% | 0.0% |
| Q3 2016 | $66,000 | +61.0% | 1,084 | -48.8% | 0.00% | +100.0% |
| Q2 2016 | $41,000 | +141.2% | 2,119 | +144.7% | 0.00% | 0.0% |
| Q1 2016 | $17,000 | -56.4% | 866 | -14.8% | 0.00% | -50.0% |
| Q4 2015 | $39,000 | +62.5% | 1,016 | +35.5% | 0.00% | 0.0% |
| Q3 2015 | $24,000 | +4.3% | 750 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $23,000 | +187.5% | 750 | +27.3% | 0.00% | +100.0% |
| Q1 2015 | $8,000 | -11.1% | 589 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $9,000 | -25.0% | 589 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $12,000 | -33.3% | 589 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $18,000 | -43.8% | 589 | -55.6% | 0.00% | 0.0% |
| Q1 2014 | $32,000 | +220.0% | 1,328 | +165.6% | 0.00% | 0.0% |
| Q4 2013 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |